Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.38M Buy
+6,694
New +$3.46M 0.31% 100
2026
Q2
– Sell
-2,343
Closed -$885K – 497
2026
Q1
$885K Buy
2,343
+509
+28% +$218K 0.09% 349
2025
Q4
$785K Sell
1,834
-4,113
-69% -$1.79M 0.11% 367
2025
Q3
$2.66M Buy
5,947
+3,055
+106% +$1.38M 0.41% 54
2025
Q2
$1.41M Buy
+2,892
New +$1.65M 0.21% 187
2024
Q3
– Sell
-931
Closed -$505K – 422
2024
Q2
$505K Buy
+931
New +$533K 0.37% 106
2023
Q2
– Sell
-1,348
Closed -$725K – 376
2023
Q1
$725K Buy
1,348
+896
+198% +$457K 0.43% 53
2022
Q4
$231K Sell
452
-226
-33% -$110K 0.5% 117
2022
Q3
$296K Buy
678
+229
+51% +$110K 1.07% 25
2022
Q2
$211K Buy
+449
New +$219K 0.41% 151
2022
Q1
– Sell
-555
Closed -$294K – 397
2021
Q4
$294K Buy
+555
New +$266K 0.23% 208

Other funds holding CHE

Oak Thistle LLC's CHE Position: Q3 2026 in Review

Oak Thistle LLC opened a new position in Chemed (CHE) in Q3 2026: 6,694 shares worth $3.38M. The stake represents 0.31% of the portfolio and ranks #100 among its holdings. This is a return to the name: Oak Thistle LLC previously reported a position in CHE as recently as Q1 2026.

Oak Thistle LLC first reported a position in CHE in Q4 2021 and has held it in 11 quarters since. 85 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Oak Thistle LLC held 6,694 shares of Chemed worth $3.38M as of Q3 2026.
  • Chemed was a new Oak Thistle LLC position in Q3 2026.
  • Chemed made up 0.31% of Oak Thistle LLC's portfolio in Q3 2026, its #100 holding.
  • Oak Thistle LLC first reported a position in Chemed in Q4 2021 and has held it in 11 quarters since.
  • 85 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Oak Thistle LLC's 13F filing for Q3 2026, filed 21 Oct 2026.